Evidence map›Paper›PMID 29402918›Full record

ArticleScientific reports2018

Droplet microfluidics for the highly controlled synthesis of branched gold nanoparticles.

Sara Abalde-Cela, Patricia Taladriz-Blanco, Marcelo Ganzarolli de Oliveira, Chris Abell

Erratum issuedAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. An Acoustofluidic Picoinjector.Sensors and actuators. B, Chemical · 2024
    Article
  6. Review
  7. Review
  8. Direct Bottom-UpChemical reviews · 2023
    Review
  9. Continuous Electroformation of Gold Nanoparticles in Nanoliter Droplet Reactors.Angewandte Chemie (International ed. in English) · 2023
    Article
  10. Article
  11. Article
  12. Microfluidic Synthesis of -NHNanomaterials (Basel, Switzerland) · 2022
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Sara Abalde-CelaDepartment of Chemistry, University of Cambridge, Lensfield Road, Cambridge, CB2 1EW, UK. sara.abalde@inl.int.ORCID http://orcid.org/0000-0001-5615-594X
Patricia Taladriz-BlancoDepartment of Chemistry, University of Cambridge, Lensfield Road, Cambridge, CB2 1EW, UK.
Marcelo Ganzarolli de OliveiraInstitute of Chemistry, University of Campinas, UNICAMP, CP 6154, 13083-970, Campinas, SP, Brazil.ORCID http://orcid.org/0000-0002-9371-9975
Chris AbellDepartment of Chemistry, University of Cambridge, Lensfield Road, Cambridge, CB2 1EW, UK.ORCID http://orcid.org/0000-0001-9174-1987

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The synthesis of anisotropic metallic nanoparticles (NPs) has been a field of intense and challenging research in the past decade. In this communication, we report on the reproducible and highly controllable synthesis of monodisperse branched gold nanoparticles in a droplet-based microfluidics platform. The process has been automated by adapting two different bulk synthetic strategies to microdroplets, acting as microreactors, for NP synthesis: a surfactant-free synthesis and a surfactant-assisted synthesis. Microdroplets were generated in two different microfluidic devices designed to accommodate the requirements of both bulk syntheses. The epitaxial growth of AuNSTs inside the microdroplets allowed for a fine control of reagent mixing and local concentrations during particle formation. This is the first time branched gold NPs have been synthesised in a microfluidics platform. The monodispersity of the product was comparable to the synthesis in bulk, proving the potential of this technology for the continuous synthesis of high quality anisotropic NPs with improved reproducibility.

Identifiers

PMID29402918
PMCPMC5799180

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.